1887

Abstract

To determine the prevalence of macrolide antibiotic and levofloxacin resistance in infections with (group A streptococcus or GAS), strains were collected from 45 medical institutions in various parts of Japan between October 2003 and September 2006. Four hundred and eighty-two strains from patients with GAS infections were characterized genetically. Strains were classified into four groups according to the type of infection: invasive infections (=74) including sepsis, cellulitis and toxic-shock-like syndrome; acute otitis media (AOM; =23); abscess (=53); and pharyngotonsillitis (=332). Among all strains, 32 types were identified; was significantly more common in invasive infections (39.2 %) and AOM (43.5 %) than in abscesses (3.8 %) or pharyngotonsillitis (10.2 %). and each accounted for 23.5 % of pharyngotonsillitis cases. Susceptibility of GAS strains to eight -lactam agents was excellent, with MICs of 0.0005–0.063 μg ml. Macrolide-resistant strains accounted for 16.2 % of all strains, while the percentages of strains possessing the resistance genes (A), (B) and (A) were 2.5 %, 6.2 % and 7.5 %, respectively. Although no strains with high resistance to levofloxacin were found, strains with an MIC of 2–4 μg ml (17.4 %) had amino acid substitutions at either Ser-79 or Asp-83 in ParC. These levofloxacin-intermediately resistant strains included 16 types, but macrolide-resistant strains were more likely than others to represent certain types.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.2008/002642-0
2008-11-01
2019-10-14
Loading full text...

Full text loading...

/deliver/fulltext/jmm/57/11/1383.html?itemId=/content/journal/jmm/10.1099/jmm.0.2008/002642-0&mimeType=html&fmt=ahah

References

  1. Beall, B., Facklam, R. & Thompson, T. ( 1996; ). Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci. J Clin Microbiol 34, 953–958.
    [Google Scholar]
  2. Billal, D. S., Fedorko, D. P., Yan, S. S., Hotomi, M., Fujihara, K., Nelson, N. & Yamanaka, N. ( 2007; ). In vitro induction and selection of fluoroquinolone-resistant mutants of Streptococcus pyogenes strains with multiple emm types. J Antimicrob Chemother 59, 28–34.
    [Google Scholar]
  3. CLSI ( 2007; ). Performance Standards for Antimicrobial Susceptibility Testing, 17th Informational Supplement, M100-S17. Wayne, PA: Clinical and Laboratory Standards Institute.
  4. Cunningham, M. W. ( 2000; ). Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 13, 470–511.[CrossRef]
    [Google Scholar]
  5. Fischetti, V. A. ( 1989; ). Streptococcal M protein: molecular design and biological behavior. Clin Microbiol Rev 2, 285–314.
    [Google Scholar]
  6. Fujita, T., Kawaguchi, T. & Fujii, Y. ( 2007; ). The closeout report: database construction of oral antimicrobial agents using the results from drug use investigations. Jpn J Antibiot 60, 265–307 (in Japanese).[CrossRef]
    [Google Scholar]
  7. Giovanetti, E., Montanari, M. P., Mingoia, M. & Varaldo, P. E. ( 1999; ). Phenotypes and genotypes of erythromycin-resistant Streptococcus pyogenes strains in Italy and heterogeneity of inducibly resistant strains. Antimicrob Agents Chemother 43, 1935–1940.
    [Google Scholar]
  8. Kimura, K., Suzuki, S., Wachino, J. I., Kurokawa, H., Yamane, K., Shibata, N., Nagano, N., Kato, H., Shibayama, K. & Arakawa, Y. ( 2008; ). First molecular characterization of group B streptococci with reduced penicillin susceptibility. Antimicrob Agents Chemother 52, 2890–2897.[CrossRef]
    [Google Scholar]
  9. Malhotra-Kumar, S., Lammens, C., Chapelle, S., Mallentjer, C., Weyler, J. & Goossens, H. ( 2005; ). Clonal spread of fluoroquinolone non-susceptible Streptococcus pyogenes. J Antimicrob Chemother 55, 320–325.[CrossRef]
    [Google Scholar]
  10. Orscheln, R. C., Johnson, D. R., Olson, S. M., Presti, R. M., Martin, J. M., Kaplan, E. L. & Storch, G. A. ( 2005; ). Intrinsic reduced susceptibility of serotype 6 Streptococcus pyogenes to fluoroquinolone antibiotics. J Infect Dis 191, 1272–1279.[CrossRef]
    [Google Scholar]
  11. Reinert, R. R., Lutticken, R. & Al-Lahham, A. ( 2004; ). High-level fluoroquinolone resistance in a clinical Streptococcus pyogenes isolate in Germany. Clin Microbiol Infect 10, 659–662.[CrossRef]
    [Google Scholar]
  12. Richter, S. S., Diekema, D. J., Heilmann, K. P., Almer, L. S., Shortridge, V. D., Zeitler, R., Flamm, R. K. & Doern, G. V. ( 2003; ). Fluoroquinolone resistance in Streptococcus pyogenes. Clin Infect Dis 36, 380–383.[CrossRef]
    [Google Scholar]
  13. Rivera, A., Rebollo, M., Sanchez, F., Navarro, F., Miro, E., Mirelis, B. & Coll, P. ( 2005; ). Characterisation of fluoroquinolone-resistant clinical isolates of Streptococcus pyogenes in Barcelona, Spain. Clin Microbiol Infect 11, 759–761.[CrossRef]
    [Google Scholar]
  14. Roberts, M. C., Sutcliffe, J., Courvalin, P., Jensen, L. B., Rood, J. & Seppälä, H. ( 1999; ). Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants. Antimicrob Agents Chemother 43, 2823–2830.
    [Google Scholar]
  15. Rogers, S., Commons, R., Danchin, M. H., Selvaraj, G., Kelpie, L., Curtis, N., Robins-Browne, R. & Carapetis, J. R. ( 2007; ). Strain prevalence, rather than innate virulence potential, is the major factor responsible for an increase in serious group A streptococcus infections. J Infect Dis 195, 1625–1633.[CrossRef]
    [Google Scholar]
  16. Ruoff, K. L., Whiley, R. A. & Beighton, D. ( 2003; ). Streptococcus. In Manual of Clinical Microbiology, pp. 405–421. Edited by P. R. Murray, E. J. Baron, J. H. Jorgensen, M. A. Pfaller & R. H. Yolken. Washington, DC: American Society for Microbiology.
  17. Seppälä, H., Skurnik, M., Soini, H., Roberts, M. C. & Huovinen, P. ( 1998; ). A novel erythromycin resistance methylase gene (ermTR) in Streptococcus pyogenes. Antimicrob Agents Chemother 42, 257–262.[CrossRef]
    [Google Scholar]
  18. Stevens, D. L., Tanner, M. H., Winship, J., Swarts, R., Ries, K. M., Schlievert, P. M. & Kaplan, E. ( 1989; ). Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med 321, 1–7.[CrossRef]
    [Google Scholar]
  19. Sunaoshi, K., Nakayama, E., Kobayashi, R., Suzuki, E., Tajima, T. & Ubukata, K. ( 2004; ). Antibiotic susceptibility and T type identification of Streptococcus pyogenes isolated from pediatric outpatients with pharingotonsillitis. Jpn J Chemother 52, 401–407.
    [Google Scholar]
  20. Tewodros, W. & Kronvall, G. ( 2005; ). M protein gene (emm type) analysis of group A beta-hemolytic streptococci from Ethiopia reveals unique patterns. J Clin Microbiol 43, 4369–4376.[CrossRef]
    [Google Scholar]
  21. Ubukata, K., Asahi, Y., Yamane, A. & Konno, M. ( 1996; ). Combinational detection of autolysin and penicillin-binding protein 2B genes of Streptococcus pneumoniae by PCR. J Clin Microbiol 34, 592–596.
    [Google Scholar]
  22. Yan, S. S., Fox, M. L., Holland, S. M., Stock, F., Gill, V. J. & Fedorko, D. P. ( 2000; ). Resistance to multiple fluoroquinolones in a clinical isolate of Streptococcus pyogenes: identification of gyrA and parC and specification of point mutations associated with resistance. Antimicrob Agents Chemother 44, 3196–3198.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.2008/002642-0
Loading
/content/journal/jmm/10.1099/jmm.0.2008/002642-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error